The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...
Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...
STOCKHOLM — Trial results are demonstrating positive findings for a single intravitreal injection gene therapy for patients with neovascular age-related macular degeneration (nAMD) who previously ...
A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The drug also showed potential efficacy in patients who failed to optimally ...
Early response to treatment with anti–vascular endothelial growth factor (VEGF) agents may predict long-term outcomes among patients with diabetic macular edema (DME), a small study suggests. "Our ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Anti-vascular endothelial growth factor (VEGF) therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback